« Back to Record
Stephen, C., Scheulen, M. E., Johnston, S., Mross, K., Cardoso, F., Dittrich, C., Eiermann, W., Hess, D., Morant, R., Semiglazov, V., Markus, B., Salzberg, M., Ostapenko, V., Illiger, H.-J., Behringer, D., Bardy-Bouxin, N., Boni, J., Kong, S., Cincotta, M., & Moore, L. (2005). Phase 2 Study of Temsirolimus (CCI-779), a Novel Inhibitor of mTOR, in Heavily Pretreated Patients With Locally Advanced or Metastatic Breast Cancer. Journal of clinical oncology, 23(23), 5314-5322.
Citation APA
Permalink
Permalink
http://hdl.handle.net/2013/ULB-DIPOT:oai:dipot.ulb.ac.be:2013/121908



